Parkside Financial Bank & Trust’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.4K Sell
355
-1
-0.3% -$37 ﹤0.01% 1535
2025
Q4
$15K Buy
356
+10
+3% +$403 ﹤0.01% 1400
2025
Q3
$11.9K Buy
346
+326
+1,630% +$9.35K ﹤0.01% 1455
2025
Q2
$548 Buy
+20
New +$579 ﹤0.01% 2496

Other funds holding VCYT

Parkside Financial Bank & Trust's VCYT Position: Q1 2026 in Review

Parkside Financial Bank & Trust reduced its Veracyte (VCYT) stake by 0.28% in Q1 2026, selling an estimated $37 and leaving 355 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1535.

Parkside Financial Bank & Trust first reported a position in VCYT in Q2 2025 and has held it in 4 quarters since. The position peaked at $15K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Parkside Financial Bank & Trust held 355 shares of Veracyte worth $11.4K as of Q1 2026.
  • Parkside Financial Bank & Trust sold 1 Veracyte share in Q1 2026, an estimated $37.
  • Veracyte made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1535 holding.
  • Parkside Financial Bank & Trust first reported a position in Veracyte in Q2 2025 and has held it in 4 quarters since.
  • Parkside Financial Bank & Trust's Veracyte position peaked at $15K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.